한글목차

세계 진해제 시장 규모는 예측 기간 동안 복합 연간 성장률(CAGR) 4.3%를 나타낼 것으로 예측됩니다. 이 시장의 주요 촉진요인은 호흡기 질환의 유병률 증가, 호흡기 시스템을 자극하여 기침을 일으키는 대기 오염 수준의 상승과 관련된 기침 방지제 수요 증가, 편리하고 즉시 사용할 수 있습니다. 치료법에 대한 수요 증가입니다. 진해제 시장의 미래는 병원, 소매 약국, 약국, 온라인 약국의 각 시장에서 기회에 의해 유망시되고 있습니다.

부문별 기침제

이 설문조사에는 세계 기침제 유형별, 약물 유형별, 투약형별, 유통 채널별, 지역별 예측이 포함되어 있습니다.

진해제 시장 인사이트

목의 상단 감염이 점점 더 염증과 간질을 일으키고 있기 때문에 마른 기침 치료제가 더 흔해지고 예측 기간 동안 마른 기침이 더 큰 부문입니다. 계속할 것 같습니다.

이 시장에서 소매 약국은 여전히 가장 큰 부문입니다.

북미는 목구멍의 박테리아 감염 사례가 증가함에 따라 예측 기간 동안 가장 규모가 큰 지역입니다.

FAQ

Q1. 시장의 성장 예측은 :

A1. 세계 진해제 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 4.3%로 성장할 것으로 예상됩니다.

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은 :

A2. 이 시장의 주요 촉진요인은 호흡기 질환의 유병률 상승할 전망이며 호흡기 시스템을 자극하고 기침을 일으키는 대기 오염 수준의 상승과 관련된 기침 약 수요 증가, 편리하고 간단합니다. 입수 가능한 치료법에 대한 수요 증가입니다.

Q3. 시장의 주요 부문은 :

A3. 세계 진해제 시장의 미래는 병원, 소매 약국, 약국, 온라인 약국의 각 시장에서 기회가 유망합니다.

Q4. 시장의 주요 기업은 :

A4. 진해제 주요 기업은 다음과 같습니다.

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Q5. 앞으로 가장 큰 시장 부문은 :

A5. 예측 기간 동안, 건성 기침은 더 큰 부문으로 지속될 것으로 예측됩니다. 이는 목의 위쪽 감염이 더 염증과 간질을 일으키기 때문에 건성 기침의 치료제가 더 인기가 있기 때문입니다.

Q6. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은:

A6. 북미는 인후 박테리아 감염 사례 증가로 예측 기간 동안 가장 규모가 큰 지역입니다.

Q7. 보고서 사용자 정의는 가능한가?

A7. 네, 추가 비용 없이 10% 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 진해제 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 산업의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018년-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 진해제 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 진해제 시장 : 유형별
  • 마른 기침
  • 습생 기침
• 세계의 진해제 시장 : 약제 유형별
  • 덱스트로메틀 팬
  • 코데인
  • 노스카핀
  • 레보드로프로피딘
  • 기타
• 세계의 진해제 시장 :제형별
  • 고체
  • 액체
  • 스프레이
• 세계의 진해제 시장 : 유통 채널별
  • 병원
  • 소매 약국
  • 약국
  • 온라인 약국
  • 기타

제4장 시장 동향과 예측 분석, 지역별(2018년-2030년)

• 세계의 진해제 시장 :지역별
• 북미 진해제 시장
• 유럽의 진해제 시장
• 아시아태평양 진해제 시장
• 기타 지역 진해제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별
  • 약제 유형별
  • 제형별
  • 유통 채널별
  • 지역별
• 세계의 진해제 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 진해제 시장의 생산 능력 확대
  • 세계의 진해제 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업의 기업 프로파일

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

영문목차

Cough Suppressant Trends and Forecast

The future of the global cough suppressant market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets. The global cough suppressant market is expected to grow with a CAGR of 4.3% from 2024 to 2030. The major drivers for this market are rising prevalence of respiratory disorders, demand for cough suppressants increases as a result of growing air pollution levels irritating the respiratory system and causing coughing, and increasing demand for convenient and readily available treatments.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Cough Suppressant by Segment

The study includes a forecast for the global cough suppressant by type, drug type, form, distribution channel, and region.

Cough Suppressant Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Dry Cough
• Wet Cough

Cough Suppressant Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

• Dextromethorphan
• Codeine
• Noscapine
• Levodropropizine
• Others

Cough Suppressant Market by Form [Shipment Analysis by Value from 2018 to 2030]:

• Solid
• Liquid
• Spray

Cough Suppressant Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• Others

Cough Suppressant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cough Suppressant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cough suppressant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cough suppressant companies profiled in this report include-

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Cough Suppressant Market Insights

Lucintel forecasts that dry cough will remain larger segment over the forecast period due to remedies for dry coughs are becoming more popular as upper throat infections are causing more and more irritation and tickling.

Within this market, retail pharmacy will remain the largest segment.

North America will remain the largest region over the forecast period due to growing cases of bacterial infection of the throat.

Features of the Global Cough Suppressant Market

Market Size Estimates: Cough suppressant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cough suppressant market size by type, drug type, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Cough suppressant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, drug type, form, distribution channel, and regions for the cough suppressant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cough suppressant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for cough suppressant market?

Answer: The global cough suppressant market is expected to grow with a CAGR of 4.3% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the cough suppressant market?

Answer: The major drivers for this market are rising prevalence of respiratory disorders, demand for cough suppressants increases as a result of growing air pollution levels irritating the respiratory system and causing coughing, and increasing demand for convenient and readily available treatments.

Q3. What are the major segments for cough suppressant market?

Answer: The future of the global cough suppressant market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets.

Q4. Who are the key cough suppressant market companies?

Answer: Some of the key cough suppressant companies are as follows:

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Q5. Which cough suppressant market segment will be the largest in future?

Answer: Lucintel forecasts that dry cough will remain larger segment over the forecast period due to remedies for dry coughs are becoming more popular as upper throat infections are causing more and more irritation and tickling.

Q6. In cough suppressant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing cases of bacterial infection of the throat.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cough suppressant market by type (dry cough and wet cough), drug type (dextromethorphan, codeine, noscapine, levodropropizine, and others), form (solid, liquid, and spray), distribution channel (hospitals, retail pharmacies, drug stores, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cough Suppressant Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cough Suppressant Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cough Suppressant Market by Type
  • 3.3.1: Dry Cough
  • 3.3.2: Wet Cough
• 3.4: Global Cough Suppressant Market by Drug Type
  • 3.4.1: Dextromethorphan
  • 3.4.2: Codeine
  • 3.4.3: Noscapine
  • 3.4.4: Levodropropizine
  • 3.4.5: Others
• 3.5: Global Cough Suppressant Market by Form
  • 3.5.1: Solid
  • 3.5.2: Liquid
  • 3.5.3: Spray
• 3.6: Global Cough Suppressant Market by Distribution Channel
  • 3.6.1: Hospitals
  • 3.6.2: Retail Pharmacies
  • 3.6.3: Drug Stores
  • 3.6.4: Online Pharmacies
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cough Suppressant Market by Region
• 4.2: North American Cough Suppressant Market
  • 4.2.1: North American Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.2.2: North American Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.3: European Cough Suppressant Market
  • 4.3.1: European Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.3.2: European Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.4: APAC Cough Suppressant Market
  • 4.4.1: APAC Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.4.2: APAC Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.5: ROW Cough Suppressant Market
  • 4.5.1: ROW Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.5.2: ROW Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cough Suppressant Market by Type
  • 6.1.2: Growth Opportunities for the Global Cough Suppressant Market by Drug Type
  • 6.1.3: Growth Opportunities for the Global Cough Suppressant Market by Form
  • 6.1.4: Growth Opportunities for the Global Cough Suppressant Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Cough Suppressant Market by Region
• 6.2: Emerging Trends in the Global Cough Suppressant Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cough Suppressant Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cough Suppressant Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Acella Pharmaceuticals
• 7.3: GlaxoSmithKline
• 7.4: Johnson & Johnson Services
• 7.5: Merck
• 7.6: Novartis International
• 7.7: Pfizer
• 7.8: Procter & Gamble
• 7.9: Reckitt Benckiser Group
• 7.10: Sanofi